Patients with gene mutations have increased risk for hereditary cancer
Knowledge enables action:
- Better understand their cancer risk
- Help them take steps to lower their risk for getting BREAST, OVARIAN, PROSTATE, or OTHER CANCERS
- Help them find it at an early stage when it's easier to treat
AMA policy encourages genetic testing under the guidance of a physician
CGx infographic: click here to view our CGx flyer.
Men & BRCA1 / BRCA2
33% of men with a BRCA1/2 mutation had a diagnosis of cancer.
Identifying individuals, including men, "at risk of carrying a BRCA1/2 mutation can be LIFESAVING and should be a part of routine medical care."
Excluding men at risk of BRCA-associated cancers is a missed opportunity.
Mutations in BRCA2 have been associated with approximately a 3 to 8.6-fold increase in the risk for prostate cancer in various studies. BRCA1 mutations increase risk by up to almost 4 fold.
Women & BRCA1 / BRCA2
50% of women who inherit a mutation will develop Breast Cancer by age 70.
2019 USPSTF Recommendation for Genetic Testing:
- Ancestry associated with BRCA1/2 mutations
- Women with prior cancers (Breast, Ovarian, Peritoneal and Fallopian Tube)
MD Labs, A Trusted Partner
Comprehensive Next Generation Sequencing Technology from AdvaGenix evaluates a panel of 138 inherited genes including BRCA1, BRCA2, Lynch Syndrome Genes, and other genes associated with an increased risk of leading cancers.